Search

New functional medical materials with antibacterial activity based on biocompatible bacterial cellulose (BC) and Ag nanoparticles (Ag NPs) were obtained. Bacterial cellulose films were prepared by stationary liquid-phase cultivation of the Gluconacetobacter hansenii strain GH-1/2008 in Hestrin-Schramm medium with glucose as a carbon source. To functionalize the surface and immobilize Ag NPs deposited by magnetron sputtering, BC films were treated with low-pressure oxygen-nitrogen plasma. The composition and structure of the nanomaterials were studied using transmission (TEM) and scanning (SEM) electron microscopy and X-ray photoelectron spectroscopy (XPS). Using electron microscopy, it was shown that on the surface of the fibrils that make up the network of bacterial cellulose, Ag particles are stabilized in the form of aggregates 5-35 nm in size. The XPS C 1s spectra show that after the deposition of Ag NPs, the relative intensities of the C-OH and O-C-O bonds are significantly reduced. This may indicate the destruction of BC oxypyran rings and the oxidation of alcohol groups. In the Ag 3d 5/2 spectrum, two states at 368.4 and 369.7 eV with relative intensities of 0.86 and 0.14 are distinguished, which are assigned to Ag 0 state and Ag acetate, respectively. Nanocomposites based on plasma-treated BC and Ag nanoparticles deposited by magnetron sputtering (BCP-Ag) exhibited antimicrobial activity against Aspergillus niger , S. aureus and Bacillus subtilis .

The Trichoderma citrinoviride VKPM F-1228 strain produces a complex of peptide-based antibiotics with antibacterial and antimycotic action. Synthesis of peptaibols is closely related to the conidiogenesis in the culture. The optimal procedure of the strain cultivation for production of peptaibols is stationary growing for 14 days at a temperature of 28 degrees C and pH 7.5 followed by formation of a dense mycelium film on the modified Saburo medium containing 30 gr/l of glucose and 12.5 gr/l of peptone. Eight individual peptaibols were extracted. The spectrum of their activity was estimated with the use of opportunistic bacteria and micromycetes as well as pathogenic clinical aspergilli. Compounds 9, 13, 14, 15 and 16 were shown active against opportunistic fungi and bacteria including methicillin resistant S. aureus, whereas compounds 9, 13 and 14 in addition showed antimycotic activity against clinical aspergilli.